Literature DB >> 3855684

Differing determinants of prognosis following resection of pulmonary metastases from osteogenic and soft tissue sarcoma patients.

J A Roth, J B Putnam, M N Wesley, S A Rosenberg.   

Abstract

A study was performed to determine if prognostic factors could be used preoperatively to predict outcome following resection of metastases. Sixty-seven soft tissue sarcoma (STS) patients (median follow-up, 36 months) and 39 osteogenic sarcoma patients (OGS) (median follow-up, 29 months) underwent thoracic exploration at the first indication of pulmonary metastases, and the results for each group were reviewed. The number of metastatic nodules, disease-free interval (DFI), and tumor doubling time (TDT) significantly correlated with postoperative survival for STS patients. Patients with four or fewer nodules on preoperative linear tomograms survived longer (median, 23 months) than patients with more than four nodules (median, 6 months; P less than 0.005). Patients with a DFI greater than 12 months had a longer survival (median, 30 months) than patients with a DFI less than or equal to 12 months (median, 10 months; P less than 0.005). Patients with a TDT greater than or equal to 20 days had a longer survival (median, 22 months) than patients with a TDT less than 20 days (median, 6 months; P less than 0.005). The only significant predictor of survival for OGS patients was the number of nodules on preoperative linear tomograms (less than or equal to 4, 37 months median survival; greater than 4, 10 months median survival; P less than 0.05). This was due to significant differences noted for the DFI and TDT distributions between OGS and STS patients, with most OGS patients having a short DFI (less than or equal to 12 months) and a rapid TDT (less than or equal to 20 days) whereas STS patients had a more heterogeneous distribution (P less than 0.01). Thus, the number of metastases visible on the preoperative tomogram was the best predictor of survival for both OGS and STS patients. However, the applicability of other prognostic factors could not be generalized for these two closely related groups of patients.

Entities:  

Mesh:

Year:  1985        PMID: 3855684     DOI: 10.1002/1097-0142(19850315)55:6<1361::aid-cncr2820550633>3.0.co;2-f

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Factors associated with pulmonary recurrence after pulmonary metastasectomy for sarcomatous disease.

Authors:  Serhan Tanju; Murat Saricam; Erkan Kaba; Murat Kapdagli; Sukru Dilege; Alper Toker
Journal:  Surg Today       Date:  2013-12-01       Impact factor: 2.549

Review 2.  Management of metastatic retroperitoneal sarcoma: a consensus approach from the Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG).

Authors: 
Journal:  Ann Oncol       Date:  2018-04-01       Impact factor: 32.976

3.  Clinical impact of the tumor volume doubling time on sarcoma patients with lung metastases.

Authors:  Tomoki Nakamura; Akihiko Matsumine; Takao Matsubara; Kunihiro Asanuma; Astumasa Uchida; Akihiro Sudo
Journal:  Clin Exp Metastasis       Date:  2011-07-30       Impact factor: 5.150

4.  Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan?

Authors:  Adriana C Gamboa; Cecilia G Ethun; Jeffrey M Switchenko; Joseph Lipscomb; George A Poultsides; Valerie Grignol; J Harrison Howard; T Clark Gamblin; Kevin K Roggin; Konstantinos Votanopoulos; Ryan C Fields; Shishir K Maithel; Keith A Delman; Kenneth Cardona
Journal:  J Am Coll Surg       Date:  2019-08-01       Impact factor: 6.113

5.  Pulmonary metastasectomy from soft tissue sarcomas.

Authors:  Rodrigo Afonso da Silva Sardenberg; Luiz Poli de Figueiredo; Fábio José Haddad; Jefferson Luiz Gross; Riad Naim Younes
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

6.  Morphology of pulmonary metastases from osteosarcoma during chemotherapy.

Authors:  T Derstappen; A Roessner; K M Müller; E Grundmann
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

7.  Multimodality therapy for metastatic sarcomas confined to the lung.

Authors:  Russell P Gollard; J Francis Turner
Journal:  Oncol Lett       Date:  2012-07-24       Impact factor: 2.967

Review 8.  Development and treatment of pulmonary metastases in adult patients with extremity soft tissue sarcoma.

Authors:  M A Gadd; E S Casper; J M Woodruff; P M McCormack; M F Brennan
Journal:  Ann Surg       Date:  1993-12       Impact factor: 12.969

9.  Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

Authors:  Allison F O'Neill; Alexander J Towbin; Mark D Krailo; Caihong Xia; Yun Gao; M Beth McCarville; Rebecka L Meyers; Eugene D McGahren; Greg M Tiao; Stephen P Dunn; Max R Langham; Christopher B Weldon; Milton J Finegold; Sarangarajan Ranganathan; Wayne L Furman; Marcio Malogolowkin; Carlos Rodriguez-Galindo; Howard M Katzenstein
Journal:  J Clin Oncol       Date:  2017-09-11       Impact factor: 44.544

10.  Surgical management of thoracic malignancy in childhood: eight years' experience in Leeds.

Authors:  J P Lodge; J R Hamilton; D R Walker; C C Bailey
Journal:  Ann R Coll Surg Engl       Date:  1988-03       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.